Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Journal of General Virology|March 22, 2007
Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1Heidi E Drummer, Irene Boo, Pantelis Poumbourios
Journal of Virology|June 22, 2007
Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 bindingKathleen McCaffrey, Irene Boo, Pantelis Poumbourios, et al.
The Journal of Biological Chemistry|July 20, 2011
Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entryJohanna Fraser, Irene Boo, Pantelis Poumbourios, et al.
Journal of Virology|July 29, 2006
A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entryHeidi E Drummer, Irene Boo, Anne L Maerz, et al.
The Journal of General Virology|October 8, 2010
The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivityKathleen McCaffrey, Hamed Gouklani, Irene Boo, et al.
Antiviral Therapy|August 3, 2007
Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodiesPatricia T K Vietheer, Irene Boo, Heidi E Drummer, et al.
The Biochemical Journal|January 14, 2012
Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2Irene Boo, Kevin teWierik, Florian Douam, et al.
Journal of Virology|January 27, 2012
Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and functionKathleen McCaffrey, Irene Boo, Kevin Tewierek, et al.
The Journal of Biological Chemistry|April 18, 2020
Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccineRob J Center, Irene Boo, Lilian Phu, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 16, 2007
Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirinIrene Boo, Alexandra E Fischer, Doug Johnson, et al.
Pageof 3